Forward Pharma A/S
DelistedCIK 1604924fmd_1VXCJDN8NNM6GRXHP62ECKFJDRManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Jun 30, 2022, 12 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | – | 1,250 | – | – | – | – |
| Research and development | 34 | 41 | 20 | 3 | 1 | 0 | 0 |
| Operating income | (50) | (55) | 1,187 | (12) | (5) | (3) | (4) |
| Income before taxes | (37) | (55) | 1,184 | (9) | (4) | (6) | (2) |
| Income tax expense | (0) | (21) | 267 | (0) | – | – | – |
| Net income from continuing operations | (37) | (33) | 917 | (9) | – | – | – |
| Net income | (37) | (33) | 917 | (9) | (4) | (6) | (2) |
| Net income to common shareholders | (37) | (33) | 917 | (9) | (4) | (6) | (2) |